[Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
Kotel'nikov
M V
MV
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D002318:Cardiovascular Diseases / Q000209:etiology; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood / Q000378:metabolism / Q000652:urine; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D008382:Marfan Syndrome / Q000235:genetics; D015337:Multicenter Studies as Topic; D009154:Mutation; D011110:Polymorphism, Genetic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D019851:Thrombophilia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000627:therapeutic use; D025101:Vitamin B 6 / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D006710:Homocysteine; D025101:Vitamin B 6; D005492:Folic Acid; D014805:Vitamin B 12